Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s263, 2023. DOI: 10.25251/skin.7.supp.263. Disponível em: https://skin.dermsquared.com/skin/article/view/2338. Acesso em: 3 apr. 2025.